Literature DB >> 34157739

Hyperbaric oxygen treatment for toxic epidermal necrolysis: A case report.

Selin Gamze Sümen1,2, Sezer Yakupoğlu3, Tuna Gümüş4, Nur Benzonana5.   

Abstract

Toxic epidermal necrolysis (TEN) is a potentially life-threatening muco-cutaneous disease, largely caused by an idiosyncratic reaction to medication or infectious disease, and is characterised by acute necrosis of the epidermis. No definitive consensus regarding the treatment of TEN has been agreed. A 60-year-old woman, diagnosed with multiple myeloma three months prior, was admitted with signs of TEN to the intensive care burns unit. She had been given ciprofloxacin to treat a urinary tract infection. She complained of malaise and pain, with maculopapular and bullous eruptions over her whole body on the third day of ciprofloxacin administration. Her supportive cares included intravenous immunoglobulins, pain control with analgesics, wound care, nutrition, and fluid support. Hyperbaric oxygen treatment (HBOT) was added on the second day of admission. The patient underwent 5 sessions of HBOT at 243.1 kPa (2.4 atmospheres absolute). Desquamation was noted to stop after the first session of HBOT and re-epithelisation commenced rapidly. The patient was discharged from the burn unit after 14 days of hospital admission. Improvement in this case was temporally related to the initiation of HBOT. Copyright: This article is the copyright of the authors who grant Diving and Hyperbaric Medicine a non-exclusive licence to publish the article in electronic and other forms.

Entities:  

Keywords:  Case reports; Drugs; Hyperbaric medicine; Outcome; Side effects; Skin; Toxicity

Mesh:

Substances:

Year:  2021        PMID: 34157739      PMCID: PMC8426128          DOI: 10.28920/dhm51.2.216-219

Source DB:  PubMed          Journal:  Diving Hyperb Med        ISSN: 1833-3516            Impact factor:   1.228


  18 in total

Review 1.  Toxic epidermal necrolysis and intravenous immunoglobulin: a review.

Authors:  Jennifer Trent; Monica Halem; Lars E French; Francisco Kerdel
Journal:  Semin Cutan Med Surg       Date:  2006-06

Review 2.  A review of toxic epidermal necrolysis management in Japan.

Authors:  Yuri Kinoshita; Hidehisa Saeki
Journal:  Allergol Int       Date:  2016-07-08       Impact factor: 5.836

3.  Hyperbaric oxygen treatment of toxic epidermal necrolysis.

Authors:  V Ruocco; D Bimonte; C Luongo; M Florio
Journal:  Cutis       Date:  1986-10

Review 4.  A Review of the Active Treatments for Toxic Epidermal Necrolysis.

Authors:  Yuri Kinoshita; Hidehisa Saeki
Journal:  J Nippon Med Sch       Date:  2017       Impact factor: 0.920

5.  Ofloxacin: a probable cause of toxic epidermal necrolysis.

Authors:  S L Melde
Journal:  Ann Pharmacother       Date:  2001-11       Impact factor: 3.154

6.  Ciprofloxacin-induced toxic epidermal necrolysis (TEN) in a nonagerian: a case report.

Authors:  Bhaskar Mandal; Michael Steward; Sudhir Singh; Hywel Jones
Journal:  Age Ageing       Date:  2004-04-28       Impact factor: 10.668

Review 7.  Toxic epidermal necrolysis (Lyell's disease).

Authors:  Mario Lissia; Pietro Mulas; Antonio Bulla; Corrado Rubino
Journal:  Burns       Date:  2009-09-18       Impact factor: 2.744

Review 8.  Drug-induced skin, nail and hair disorders.

Authors:  Laurence Valeyrie-Allanore; Bruno Sassolas; Jean-Claude Roujeau
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 9.  Review of Toxic Epidermal Necrolysis.

Authors:  Victoria Harris; Christopher Jackson; Alan Cooper
Journal:  Int J Mol Sci       Date:  2016-12-18       Impact factor: 5.923

10.  Hyperbaric Oxygen Therapy: Exploring the Clinical Evidence.

Authors:  Gretl Lam; Rocky Fontaine; Frank L Ross; Ernest S Chiu
Journal:  Adv Skin Wound Care       Date:  2017-04       Impact factor: 2.347

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.